2022 EHA | 中国专家国际发声，124篇Poster入选！（二）

2022 EHA 中国专家ePoster汇总

1.摘要号：P364

题目：DONOR-DERIVED CD19 CAR-T CELLS AND CHEMOTHERAPY PLUS DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF RECURRENT CD19+B-ALL AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

报告人：张曦

单位：陆军军医大学第二附属医院（新桥医院）

2.摘要号：P377

题目：GENETIC CHARACTERISTICS AND CD7-CAR-T THERAPY OF TRAD:MYC TRANSLOCATION POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

报告人：刘红星

单位：河北燕达陆道培医院

3.摘要号：P480

题目：NKG2D-MEDIATED ANTI-TUMOR IMMUNITY CONTRIBUTES TO THE FAVORABLE PROGNOSIS IN APL

报告人：王怀宇

单位：西安交通大学第一附属医院

4.摘要号：P554

题目：GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY FOR RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA:A PHASE 3，RANDOMIZED，MULTICENTER，OPEN-LABEL TRIAL IN ASIA

报告人：王建祥

单位：中国医学科学研血液病医院（天津血研所）

5.摘要号：P625

题目：SINGLE-CELL RNA SEQUENCING REVEALS THE HETEROGENEITY OF TUMOR CELLS AND IMMUNE MICROENVIRONMENT IN RICHTER SYNDROME AND ACCELERATED CLL

报告人：Yeqin Sha

单位：南京医科大学第一附属医院

6.摘要号：P734

题目：DOWN-REGULATION OF RING1 AND YY1 BINDING（RYBP）LEADS TO EPIGENETIC OVEREXPRESSION OF ANTI-APOPTOTIC PROTEIN BCL2 IN MYELODYSPLASTIC SYNDROMES

报告人：许峰

单位：上海市第六人民医院

7.摘要号：P749

题目：PROGNOSTIC SIGNIFICANCE OF SERIAL CIRCULATING TUMOR DNA STATUS POST TREATMENT IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

报告人：佟红艳

单位：浙江大学附属第一医院

8.摘要号：P759

题目：CORRELATION ANALYSIS OF DNA METHYLATION LEVEL AND CLINICAL CHARACTERISTICS IN JMML PATIENTS

报告人：Yuli Cai

单位：中国医学科学院血液病医院

9.摘要号：P780

题目：COMBINATION THERAPY OF ELTROMBOPAG AND CYCLOSPORINE A CAN IMPROVE HEMATOPOIESIS IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROME

报告人：Luxi Song

单位：上海市第六人民医院

10.摘要号：P786

题目：ANTI-PD-1 ANTIBODY（SINTILIMAB）PLUS DECITABINE AS FIRST LINE TREATMENT FOR PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME（MDS）：PRELIMINARY RESULTS FROM A SINGLE-ARM，OPEN-LABEL，PHASE II STUDY

报告人：Jing Wang

单位：北京大学人民医院

11.摘要号：P789

题目：ANALYSIS OF THE CLINICAL FEATURES，PROGNOSIS AND GENE MUTATIONS IN PRIMARY MYELODYSPLASTIC SYNDROME PATIENTS WITH MYELOFIBROSI

报告人：Gaixiang Xu

单位：浙江大学附属第一医院

12.摘要号：P790

题目：THE EXPRESSION LEVEL OF WT1 MRNA IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE（ICUS） PROGRESSING TO MYELODYSPLASTIC SYNDROME（MDS）

报告人：Xingnong Ye

单位：浙江大学附属第一医院

13.摘要号：P796

题目：ENRICHED CD16+MONOCYTES DRIVE T LYMPHOCYTES CELL RESPONSES IN APLASTIC ANEMIA

报告人：Meili Ge

单位：中国医学科学院血液病医院

14.摘要号：P820

题目：PREDICTING RESPONSE TO RABBIT ATG-BASED INTENSIVE IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG IN CHINESE ADULT PATIENTS WITH SEVERE APLASTIC ANEMIA

报告人：何广胜

单位：南京医科大学第一附属医院

15.摘要号：P823

题目：THE INCIDENCE，OUTCOMES，AND RISK FACTORS OF SECONDARY POOR GRAFT FUNCTION IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA

报告人：Fan Lin

单位：北京大学血液病研究所

16.摘要号：P878

题目：HIGH MUTATIONAL BURDEN OF CHROMATIN MODIFYING GENES DEFINES A RELATIVELY INDOLENT SUBGROUP OF PLASMA CELL DYSCRASIAS

报告人：Xuezhu Wang

单位：北京协和医院

17.摘要号：P882

题目：IDENTIFICATION OF M7G RNA METHYLATION REGULATORS AND M7G-RELATED GENES IN MULTIPLE MYELOMA

报告人：Manya Yu

单位：山东中医药大学

18.摘要号：P883

题目：TARGETING CALCINEURIN/NFATC1 SIGNALING SENSITIZES PROTEASOME INHIBITION TREATMENT IN MULTIPLE MYELOMA

报告人：Jinglin Zhang

单位：香港中文大学

19.摘要号：P903

题目：DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED PATIENTS WITH MAYO 2004 STAGE 3 LIGHT-CHAIN AMYLOIDOSIS: A PROSPECTIVE PHASE 2 STUDY

报告人：Ya-juan Gao

单位：北京协和医院

20.摘要号：P909

题目：RENAL RESPONSE OF POMALIDOMIDE WITH BORTEZOMIB AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT

报告人：高文

单位：首都医科大学附属北京朝阳医院

21.摘要号：P920

题目：EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA

报告人：李娟

单位：中山大学第一附属医院

22.摘要号：P927

题目：CLINICAL CHARACTERISTICS, SURVIVAL OUTCOMES AND PROGNOSIS IN 123IMMUNOGLOBULIN D MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE SINGLE-CENTER

报告人：Jiahui Liu

单位：中国医学科学院血液病医院

23.摘要号：P944

题目：A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

报告人：Xiaoyan Qu

单位：南京医科大学第一附属医院

24.摘要号：P969

题目：COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS

报告人：Siyuan Cui

单位：山东中医药大学附属医院

25.摘要号：P970

题目：SAFETY AND EFFICACY OF BCMA-CAR-T IMMUNE CELLS DERIVED FROM CORD BLOOD IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA

报告人：Ying Gao

单位：陕西省人民医院

26.摘要号：P1047

题目：REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA

报告人：肖志坚

单位：中国医学科学院血液病医院

27.摘要号：P1090

题目：CAMRELIZUMAB (CAM) COMBINED WITH GEMOX CHEMOTHERAPY RESULTS IN HIGH COMPLETE METABOLIC RESPONSE RATES IN RELAPSED/REFRACTORY CLASSIC HODGKIN LYMPHOMA (CHL): A PHASE II TRIAL

报告人：Yan Xie

单位：北京大学肿瘤医院

28.摘要号：P1106

题目：PRELIMINARY RESULTS OF A PHASE 1 STUDY OF NOVEL BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) IN CHINESE PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMAS (NHLS)

报告人：Mingyuan Sun

单位：中国医学科学院血液病医院

29.摘要号：P1118

题目：PROGNOSTIC SIGNIFICANCE OF ABSOLUTE MONOCYTE COUNT AND LYMPHOCYTE TO MONOCYTE RATIO IN MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA

报告人：Yue Li

单位：南京医科大学第一附属医院

30.摘要号：P1120

题目：THE EFFICACY AND SAFETY OF ZANUBRUTINIB AND DEXAMETHASONE IN SYMPTOMATIC WALDENSTROM MACROGLOBULINNEMIA

报告人：陈文明

单位：首都医科大学附属北京朝阳医院

31.摘要号：P1185

题目：ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY.

报告人：C. Li

单位：苏州大学第一附属医院

32.摘要号：P1219

题目：ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL)

报告人：朱华渊

单位：南京医科大学第一附属医院

33.摘要号：P1223

题目：PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZRMA REGIMEN（ZANUBRUTINIB, RITUXIMAB, METHOTREXATE AND CYTARABINE）

报告人：Youhong Tang

单位：中南大学湘雅医院

34.摘要号：P1234

题目：REAL-WORLD EXPERIENCE OF OUTCOMES WITH GLOFITAMAB SALVAGE THERAPY FOR RELAPSE/REFRACTORY B-CELL LYMPHOMA IN TAIWAN: MINIMAL SAFETY CONCERN WITH HEPATITIS B REACTIVATION

报告人：Shang-Ju Wu

单位：国立台湾大学医学院副设医院

35.摘要号：P1235

题目：GENOTYPING ON CIRCULATING TUMOR DNA IMPROVES MUTATION DETECTION RATE IN HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA

报告人：徐卫

单位：南京医科大学第一附属医院

36.摘要号：P1243

题目：RUXOLITINIB COMBINED WITH DEXAMETHASONE IN ADULT PATIENTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: INTERIM ANALYSIS OF A PROSPECTIVE, SINGLE-CENTER, SINGLE-ARM, PHASE 2 CLINICAL TRIAL

报告人：De Zhou

单位：浙江大学附属第一医院

37.摘要号：P1280

题目：TARGETED INHIBITION OF DHODH IS SYNERGISTIC WITH BCL2 BLOCKADE IN LYMPHOMA WITH CONCURRENT MYC AND BCL2 REARRANGEMENT

报告人：闫晓菁

单位：中国医科大学第一附属医院 

38.摘要号：P1305

题目：HSA_CIRC_0001599 REGULATES IL18 LEVELS IN AGVHD VIA CERNA MECHANISM

报告人：Mengting Xia

单位：山东中医药大学

39.摘要号：P1315

题目：ENGRAFTMENT AND MOBILIZATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS ALIGNS WITH DYNAMIC OSCILLATION OF TETRASPANIN CD9

报告人：Wing Hei Ng

单位：香港中文大学

40.摘要号：P1327

题目：RUXOLITINIB COMBINED WITH GLUCOCORTICOID IN THE FIRST-LINE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN CHILDREN: A SINGLE CENTER RETROSPECTIVE STUDY

报告人：Kai Chen

单位：上海市儿童医院

41.摘要号：P1341

题目：HAPLO-CORD VS HAPLOIDENTICAL TRANSPLANT IN 49 CHILDREN – A RETROSPECTIVE SINGLE CENTER ANALYSIS

报告人：Pan Fu

单位：上海市儿童医院

42.摘要号：P1375

题目：SECOND PRIMARY MALIGNANCY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

报告人：Tran-Der Tan

单位：中国台湾顾氏基金孙中山癌症中心

43.摘要号：P1388

题目：A SINGLE-ARM, PROSPECTIVE MULTICENTER CLINICAL STUDY OF RELATED HLA HAPLOIDENTICAL PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION FOR HEMATOLOGICAL MALIGNAN

报告人：Ming Jiang

单位：新疆医科大学第一附属医院

44.摘要号：P1390

题目：THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED REGIMEN FOR ALLOGENEIC TRANSPLANTATION IN REFRACTORY/RELAPSED AML PATIENTS

报告人：Shulian Chen

单位：中国医学科学院血液病医院

45.摘要号：P1391

题目：COMPARISON OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST COMPLETE REMISSION

报告人：Rongli Zhang

单位：中国医学科学院血液病医院

46.摘要号：P1452

题目：THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS

报告人：Li Liu

单位：第四军医大学唐都医院

47.摘要号：P1465

题目：INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

报告人：Li Wang

单位：解放军第923医院

48.摘要号：P1603

题目：CLINICAL OBSERVATION OF PATHOGEN MICROBIAL NEXT-GENERATION SEQUENCING ASSISTED IN INFECTION DIAGNOSIS AND TREATMENT OF PATIENTS WITH HEMATOLOGICAL TUMORS

报告人：张曦

单位：陆军军医大学第二附属医院(新桥医院)

49.摘要号：P1604

题目：DISTRIBUTION AND ANTIBIOTIC RESISTANCE PROFILE OF PATHOGENIC MICROORGANISMS CAUSING NOSOCOMIAL INFECTION IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION

报告人：Yimei Feng

单位：陆军军医大学第二附属医院(新桥医院)

50.摘要号：P1617

题目：CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS DRUG RESISTANCE GENE MUTATIONS IN CYTOMEGALOVIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

报告人：Jingjing Wen

单位：电子科技大学医学院附属绵阳医院

51.摘要号：P1634

题目：EFFICACY AND SAFETY OF ELTROMBOPAG IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION PATIENTS WITH THROMBOCYTOPENIA（HBV-TP）: A PROSPECTIVE, MULTI-CENTER, SINGLE ARM, PHASE II TRAIL

报告人：Yunfei Chen

单位：中国医学科学院血液病医院

52.摘要号：P1641

题目：ELTROMBOPAG TREATMENT, OUTCOMES AFTER DISCONTINUATION IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA, AND EXPLORATION OF POTENTIAL PREDICTIVE FACTORS: A REAL-WORLD CLINICAL EXPERIENCE

报告人：Xiaofan Liu

单位：中国医学科学院血液病医院

53.摘要号：P1670

题目：LONG TERM SAFETY AND EFFICACY OF RECOMBINANT HUMAN COAGULATION FACTOR VIII (SCT800) IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A

报告人：Feng Xue

单位：中国医学科学院血液病医院

54.摘要号：P1716

题目：REGULAR HOSPITAL VISITS IMPROVE THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS

报告人：Xiaozhe Li

单位：中山大学附属第一医院

55.摘要号：P1737

题目：QUALITY OF LIFE IN CHILDREN WITH BETA-THALASSEMIA MAJOR: A CROSS-SECTIONAL STUDY IN CHINA

报告人：Zhen Song

单位：中国医学科学院血液病医院

注：排名不分先后，按照摘要号进行，如有遗漏，请给我们留言~